Clinical Trial Update: The TRICURE EU Pivotal Study [NA]

View source ↗

Summary

The TRiCURE EU pivotal study for tricuspid valve regurgitation is currently recruiting, sponsored by TRiCares, with indications in heart valve disease and broad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Valve Disease
• Tricuspid Valve Regurgitation

Snippet

Sponsor: TRiCares | Conditions: Tricuspid Valve Regurgitation, Heart Valve Disease | NA | Status: RECRUITING